Mika Gissler, MSocSc, PhD
Information Services Department, THL Finnish Institute for Health and Welfare, Helsinki, Finland; Research Centre for Child Psychiatry, University of Turku, Turku, Finland; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Academic Primary Health Care Centre, Region Stockholm, Stockholm, Sweden
Original Research
Atomoxetine and Prevalence of Major Congenital Malformations
January 16, 2023
Little is known about the safety of atomoxetine, a non-stimulant treatment for attention-deficit/hyperactivity disorder. This study assessed the prevalence of major congenital malformations after first-trimester exposure to atomoxetine.
